A new mutation in DNM2 gene in a large Italian family

Abstract

The Charcot-Marie-Tooth (CMT) disease is the most common inherited peripheral neuropathy with great clinical and genetic heterogeneity. Mutations in DNM2 have been associated with CMT dominant intermediate B (CMTDIB). However, mutations in the same gene are known to induce also axonal CMT (CMT2M) or centronuclear myopathy. Moreover, the ability of effectively and simultaneously sequencing different CMT-related genes by next-generation sequencing approach makes it possible to detect even the presence of modifier genes that sometimes give reason of clinical variability in the context of complex phenotypes. Here, we describe an Italian family with very variable severity of phenotype among members harboring a novel DNM2 gene mutation which caused a prevalent CMT2M phenotype. The contemporary presence of a de novo variant in PRX gene in the most severely affected family member suggests a possible modulator effect of the PRX variant thus highlighting the possible impact of modifier genes in CMT.

This is a preview of subscription content, access via your institution.

Fig. 2
Fig. 1

References

  1. 1.

    Barisic N, Claeys KG, Sirotković-skerlev M et al (2008) Charcot-Marie-Yooth disease: a clinico-genetic confrontation. Ann Hum Genet. 72:416–441. https://doi.org/10.1111/j.1469-1809.2007.00412.x

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Pisciotta C, Shy ME (2018) Neuropathy. In: Handbook of Clinical Neurology. https://doi.org/10.1016/B978-0-444-64076-5.00042-9

  3. 3.

    Salisachs P (1974) Wide spectrum of motor conduction velocity in charcot-marie-tooth disease. An anatomico-physiological interpretation. J Neurol Sci 23:25–31. https://doi.org/10.1016/0022-510X(74)90138-5

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Fallerini C, Carignani G, Capoccitti G, Federico A, Rufa A, Pinto AM, Rizzo CL, Rossi A, Mari F, Mencarelli MA, Giannini F, Renieri A (2015) Sporadic hereditary motor and sensory neuropathies: advances in the diagnosis using next generation sequencing technology. J Neurol Sci. 359:409–417. https://doi.org/10.1016/j.jns.2015.09.377

    Article  PubMed  Google Scholar 

  5. 5.

    Berciano J, García A, Gallardo E, Peeters K, Pelayo-Negro AL, Álvarez-Paradelo S, Gazulla J, Martínez-Tames M, Infante J, Jordanova A (2017) Intermediate Charcot–Marie–Tooth disease: an electrophysiological reappraisal and systematic review. J Neurol. 264:1655–1677. https://doi.org/10.1007/s00415-017-8474-3

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Cortese A, Wilcox JE, Polke JM, Poh R, Skorupinska M, Rossor AM, Laura M, Tomaselli PJ, Houlden H, Shy ME, Reilly MM (2020) Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease. Neurology. 94:e51–e61. https://doi.org/10.1212/WNL.0000000000008672

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Saporta ASD, Sottile SL, Miller LJ, Feely SME, Siskind CE, Shy ME (2011) Charcot-marie-tooth disease subtypes and genetic testing strategies. Ann Neurol. 69:22–33. https://doi.org/10.1002/ana.22166

    Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Høyer H, Braathen GJ, Busk ØL, Holla ØL, Svendsen M, Hilmarsen HT, Strand L, Skjelbred CF, Russell MB (2014) Genetic diagnosis of Charcot-Marie-Tooth disease in a population by next-generation sequencing. Biomed Res Int. 2014:1–13. https://doi.org/10.1155/2014/210401

    CAS  Article  Google Scholar 

  9. 9.

    Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, Thomas NST, Cooper DN (2009) The human gene mutation database: 2008 update. Genome Med. 1:13. https://doi.org/10.1186/gm13

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Chen S, Huang P, Qiu Y, Zhou Q, Li X, Zhu M, Hong D (2018) Phenotype variability and histopathological findings in patients with a novel DNM2 mutation. Neuropathology. 38:34–40. https://doi.org/10.1111/neup.12432

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Züchner S, Noureddine M, Kennerson M, Verhoeven K, Claeys K, Jonghe PD, Merory J, Oliveira SA, Speer MC, Stenger JE, Walizada G, Zhu D, Pericak-Vance MA, Nicholson G, Timmerman V, Vance JM (2005) Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet. 37:289–294. https://doi.org/10.1038/ng1514

    CAS  Article  PubMed  Google Scholar 

  12. 12.

    Fabrizi GM, Ferrarini M, Cavallaro T, Cabrini I, Cerini R, Bertolasi L, Rizzuto N (2007) Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease. Neurology. 69:291–295. https://doi.org/10.1212/01.wnl.0000265820.51075.61

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Bitoun M, Maugenre S, Jeannet PY, Lacène E, Ferrer X, Laforêt P, Martin JJ, Laporte J, Lochmüller H, Beggs AH, Fardeau M, Eymard B, Romero NB, Guicheney P (2005) Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet. 37:1207–1209. https://doi.org/10.1038/ng1657

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Koutsopoulos OS, Kretz C, Weller CM, Roux A, Mojzisova H, Böhm J, Koch C, Toussaint A, Heckel E, Stemkens D, ter Horst SAJ, Thibault C, Koch M, Mehdi SQ, Bijlsma EK, Mandel JL, Vermot J, Laporte J (2013) Dynamin 2 homozygous mutation in humans with a lethal congenital syndrome. Eur J Hum Genet. 21:637–642. https://doi.org/10.1038/ejhg.2012.226

    CAS  Article  PubMed  Google Scholar 

  15. 15.

    Bitoun M, Bevilacqua JA, Prudhon B, Maugenre S, Taratuto AL, Monges S, Lubieniecki F, Cances C, Uro-Coste E, Mayer M, Fardeau M, Romero NB, Guicheney P (2007) Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset. Ann Neurol. 62:666–670. https://doi.org/10.1002/ana.21235

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    Gallardo E, Claeys KG, Nelis E, García A, Canga A, Combarros O, Timmerman V, Jonghe P, Berciano J (2008) Magnetic resonance imaging findings of leg musculature in Charcot-Marie-Tooth disease type 2 due to dynamin 2 mutation. J Neurol. 255:986–992. https://doi.org/10.1007/s00415-008-0808-8

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Böhm J, Biancalana V, DeChene ET et al (2012) Mutation spectrum in the large gtpase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy. Hum Mutat. 33:949–959. https://doi.org/10.1002/humu.22067

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Massana Muñoz X, Buono S, Koebel P, Laporte J, Cowling BS (2019) Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy. Hum Mol Genet. https://doi.org/10.1093/hmg/ddz249

  19. 19.

    Niemann A, Berger P, Suter U (2006) Pathomechanisms of mutant proteins in charcot-marie-tooth disease. NeuroMolecular Med. 8:217–241. https://doi.org/10.1385/NMM:8:1-2:217

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Claeys KG, Züchner S, Kennerson M et al (2009) Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy. Brain 132:1741–1752

    Article  Google Scholar 

Download references

Funding

The authors thank the Cell lines and DNA bank of the Rett syndrome, X-linked mental retardation, and other genetic diseases, members of the Telethon Network of Genetic Biobanks (project no. GTB18001), funded by Telethon Italy, and the EuroBioBank network, for financial support.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Alessandra Renieri.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lopergolo, D., Bocci, S., Pinto, A.M. et al. A new mutation in DNM2 gene in a large Italian family. Neurol Sci (2021). https://doi.org/10.1007/s10072-020-04972-8

Download citation

Keywords

  • Charcot-Marie-Tooth (CMT) disease
  • DNM2
  • Modifier genes